Page last updated: 2024-08-17

quinoxalines and Alcohol Drinking

quinoxalines has been researched along with Alcohol Drinking in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.45)18.2507
2000's3 (10.34)29.6817
2010's24 (82.76)24.3611
2020's1 (3.45)2.80

Authors

AuthorsStudies
Bauer, MR; Boehm, SL; Garcy, DP1
Babinska, Z; Getachew, B; Luptak, M; Ruda-Kucerova, J; Tizabi, Y1
Brath, H; Fasching, P; Kaser, S; Tatschl, C1
Ginsburg, BC; Lamb, RJ2
Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D1
Rahman, S; Sajja, RK1
Kaminski, BJ; Weerts, EM1
Bartlett, SE; Feduccia, AA; Mill, D; Simms, JA; Yi, HY1
Anton, RF; Henderson, S; Li, X; Myrick, H; Randall, PK; Schacht, JP1
Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA1
Erwin, BL; Slaton, RM1
Gubner, NR; McKinnon, CS; Phillips, TJ1
Chaudhri, N; Janak, PH; Reese, RM; Sciascia, JM1
Chapin, DS; Freeman, J; Guanowsky, V; Hajós, M; Hoffmann, WE; Horner, WE; Johnson, DE; Kozak, R; Majchrzak, MJ; McLean, S; Rollema, H; Seymour, PA; Williams, KE1
Booij, J; Crunelle, CL; Miller, ML; van den Brink, W1
Anthenelli, RM; Arteaga, C; Heffner, JL; Lee, TC1
Andersen, J; Kamens, HM; Picciotto, MR1
Gardner, PD; Hendrickson, LM; Pang, X; Tapper, AR; Zhao-Shea, R1
Fucito, LM; O'Malley, SS; Romano, DM; Tek, E; Toll, BA; Wu, R1
Bartlett, SE; Bito-Onon, JJ; Chatterjee, S; Holgate, J; Simms, JA1
Childs, E; de Wit, H; King, AC; Roche, DJ1
Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH1
Besheer, J; Cannady, R; Durant, B; Fisher, KR; Hodge, CW1
Borland, R; Cummings, KM; Fong, GT; Harrison, EL; Hyland, A; Kahler, CW; McKee, SA; Young-Wolff, KC1
Busto, UE; Cassels, BK; Gysling, K; Quintanilla, ME; Sotomayor-Zárate, R; Tampier, L1
Carvalho, LC; de Moura, RS; Madeira, SV; Miranda, DZ; Pinto, AC; Rangel, BM; Resende, AC; Rubenich, LM; Sicca, RF; Souza, MA; Tano, T1
O'Neill, MF; Tomkins, DM1
Karpukhina, EP; Nikitin, AV; Simvolokov, SI1

Reviews

3 review(s) available for quinoxalines and Alcohol Drinking

ArticleYear
[Smoking, alcohol and diabetes (Update 2019)].
    Wiener klinische Wochenschrift, 2019, Volume: 131, Issue:Suppl 1

    Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2019
Varenicline in the treatment of alcohol use disorders.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:11

    Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline

2014
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2

    Topics: Alcohol Drinking; Animals; Behavior, Addictive; Benzazepines; Brain; Dopamine; Drug Partial Agonism; Humans; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Secondary Prevention; Smoking Cessation; Substance-Related Disorders; Varenicline

2010

Trials

6 trial(s) available for quinoxalines and Alcohol Drinking

ArticleYear
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Psychopharmacology, 2014, Volume: 231, Issue:18

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reward; Varenicline; Young Adult

2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
    Psychopharmacology, 2014, Volume: 231, Issue:19

    Topics: Adult; Alcohol Drinking; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult

2014
Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials.
    Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3

    Topics: Adult; Alcohol Drinking; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2010
A preliminary investigation of varenicline for heavy drinking smokers.
    Psychopharmacology, 2011, Volume: 215, Issue:4

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2011
Varenicline decreases alcohol consumption in heavy-drinking smokers.
    Psychopharmacology, 2012, Volume: 223, Issue:3

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2012

Other Studies

20 other study(ies) available for quinoxalines and Alcohol Drinking

ArticleYear
Systemic Administration of the AMPA Receptor Antagonist, NBQX, Reduces Alcohol Drinking in Male C57BL/6J, But Not Female C57BL/6J or High-Alcohol-Preferring, Mice.
    Alcoholism, clinical and experimental research, 2020, Volume: 44, Issue:11

    Topics: Alcohol Drinking; Animals; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinoxalines; Receptors, AMPA; Sex Factors

2020
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats.
    Neuroscience letters, 2018, 02-14, Volume: 666

    Topics: Alcohol Drinking; Animals; Depression; Kainic Acid; Ketamine; Male; Quinoxalines; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate

2018
Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure.
    Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:7

    Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Operant; Dose-Response Relationship, Drug; Eating; Ethanol; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Inbred Lew; Self Administration; Treatment Outcome; Varenicline

2013
Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 110

    Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Quinolizines; Quinoxalines; Varenicline

2013
The effects of varenicline on alcohol seeking and self-administration in baboons.
    Alcoholism, clinical and experimental research, 2014, Volume: 38, Issue:2

    Topics: Alcohol Drinking; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Male; Papio; Quinoxalines; Self Administration; Varenicline

2014
Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.
    British journal of pharmacology, 2014, Volume: 171, Issue:14

    Topics: Alcohol Drinking; Animals; Benzazepines; Dopamine; Dose-Response Relationship, Drug; Ethanol; Male; Microinjections; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Structure-Activity Relationship; Varenicline

2014
Relative potency of varenicline or fluvoxamine to reduce responding for ethanol versus food depends on the presence or absence of concurrently earned food.
    Alcoholism, clinical and experimental research, 2014, Volume: 38, Issue:3

    Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Operant; Eating; Ethanol; Fluvoxamine; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Inbred Lew; Reinforcement, Psychology; Self Administration; Treatment Outcome; Varenicline

2014
Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.
    Alcoholism, clinical and experimental research, 2014, Volume: 38, Issue:12

    Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Psychological; Ethanol; Female; Male; Mice; Mice, Inbred DBA; Motor Activity; Quinoxalines; Varenicline

2014
Alcohol-Seeking Triggered by Discrete Pavlovian Cues is Invigorated by Alcohol Contexts and Mediated by Glutamate Signaling in the Basolateral Amygdala.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:12

    Topics: Alcohol Drinking; Amygdala; Analysis of Variance; Animals; Central Nervous System Depressants; Conditioning, Classical; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Excitatory Amino Acid Antagonists; Glutamates; Male; Quinoxalines; Rats; Rats, Long-Evans; Signal Transduction

2015
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
    Biochemical pharmacology, 2009, Oct-01, Volume: 78, Issue:7

    Topics: Affect; Alcohol Drinking; Animals; Attention; Benzazepines; Cerebral Cortex; Cognition; Depression; Drug Partial Agonism; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Recognition, Psychology; Reflex, Startle; Reward; Tobacco Use Disorder; Varenicline

2009
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Psychopharmacology, 2010, Volume: 208, Issue:4

    Topics: Alcohol Drinking; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Choice Behavior; Dose-Response Relationship, Drug; Drinking Behavior; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Varenicline

2010
Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jul-28, Volume: 30, Issue:30

    Topics: Alanine; Alcohol Drinking; Analysis of Variance; Animals; Benzazepines; Central Nervous System Depressants; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drinking Behavior; Drug Combinations; Ethanol; Gene Expression Regulation; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; Nicotinic Agonists; Proto-Oncogene Proteins c-fos; Quinoxalines; Receptors, Nicotinic; Tyrosine 3-Monooxygenase; Varenicline; Ventral Tegmental Area

2010
Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Addiction biology, 2011, Volume: 16, Issue:3

    Topics: Alcohol Drinking; Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Neurons; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Stimulation, Chemical; Varenicline

2011
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.
    Alcoholism, clinical and experimental research, 2012, Volume: 36, Issue:5

    Topics: Adult; Affect; Alcohol Drinking; Alcohol-Related Disorders; Benzazepines; Central Nervous System Depressants; Ethanol; Eye Movements; Female; Humans; Male; Nausea; Nicotinic Agonists; Quinoxalines; Varenicline; Young Adult

2012
Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
    Addiction biology, 2013, Volume: 18, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Analysis of Variance; Animals; Conditioning, Operant; Cues; Disease Models, Animal; Ethanol; Excitatory Amino Acid Antagonists; Glutamates; Linear Models; Male; Motor Activity; Nootropic Agents; Pyrrolidinones; Quinoxalines; Rats; Receptors, AMPA; Recurrence; Reinforcement, Psychology; Self Administration; Sucrose

2013
Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey.
    Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:5

    Topics: Adult; Alcohol Drinking; Benzazepines; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
    Psychopharmacology, 2013, Volume: 227, Issue:2

    Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Chile; Dose-Response Relationship, Drug; Drinking; Drug Administration Schedule; Ethanol; Male; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Saccharin; Time Factors; Varenicline

2013
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3

    Topics: Acetylcholine; Administration, Oral; Alcohol Drinking; Animals; Apamin; Atropine; Blood Pressure; Bradykinin; Brazil; Charybdotoxin; Clonidine; Deoxycholic Acid; Drug Therapy, Combination; Endothelium, Vascular; Flavonoids; Glyburide; Guanylate Cyclase; Hypertension; Indomethacin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; Oxadiazoles; Perfusion; Phenols; Polyphenols; Potassium Chloride; Pressure; Pyrilamine; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Wine; Yohimbine

2004
Effect of 5-HT(1B) receptor ligands on self-administration of ethanol in an operant procedure in rats.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 66, Issue:1

    Topics: Alcohol Drinking; Animals; Conditioning, Operant; Ethanol; Indoles; Male; Oxadiazoles; Piperazines; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Self Administration

2000
[The clinico-immunological efficacy of dioxidine in the combined treatment of acute abscessing pneumonias in persons who abuse alcohol].
    Terapevticheskii arkhiv, 1990, Volume: 62, Issue:1

    Topics: Acute Disease; Adult; Aged; Alcohol Drinking; Alcoholism; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Drug Evaluation; Female; Humans; Immunity; Lipid Peroxidation; Lung Abscess; Male; Middle Aged; Quinoxalines

1990